What is the management for post-D&C (dilation and curettage) bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Post-D&C Bleeding

For post-D&C bleeding, the first-line management should include assessment of bleeding severity, local compression, and uterotonic medications such as oxytocin, followed by surgical interventions if bleeding persists.

Initial Assessment and Management

Assess Bleeding Severity

  • Determine if bleeding meets criteria for major bleeding:
    • Bleeding at a critical site
    • Hemodynamic instability
    • Clinically overt bleeding with hemoglobin decrease ≥2 g/dL or requiring ≥2 units of blood 1

First-Line Interventions

  1. Local compression

    • Apply direct pressure/compression to control bleeding 1
    • Consider vaginal packing if appropriate
  2. Pharmacological management

    • Oxytocin: 10-40 units in 1000 mL of IV fluid, infused at a rate necessary to control uterine atony 2
    • Alternative: 10 units IM after placental delivery 2
  3. Volume resuscitation

    • Initiate fluid therapy using 0.9% NaCl or balanced crystalloid solution if significant bleeding 1
    • Target hemoglobin of 70-90 g/L if transfusion becomes necessary 1

Second-Line Interventions

If bleeding persists despite first-line measures:

Surgical Management

  1. Repeat curettage

    • Consider repeat D&C if retained products of conception are suspected
    • CAUTION: Repeat curettage may worsen bleeding if a pseudoaneurysm is present 3
  2. Uterine packing

    • Early packing can reduce or stop venous bleeding 1
    • Consider leaving packing in place for 24-48 hours to lower risk of rebleeding 1

Advanced Interventions

  1. Angiographic embolization

    • Gold standard for treatment of pseudoaneurysms 3
    • Consider if bleeding persists despite other measures
    • Allows for both diagnosis and treatment simultaneously
    • Preserves fertility compared to more invasive surgical options 3
  2. Hysteroscopy

    • Allows direct visualization of the endometrial cavity and endocervix 1
    • Can diagnose focal lesions possibly missed by initial D&C 1
    • Operative hysteroscopy (CPT code 58558) can be used for treatment of identified pathology 4

Special Considerations

Delayed Bleeding

  • Consider pseudoaneurysm of the uterine artery if bleeding occurs days to weeks after D&C 3
  • Diagnostic features: anechoic area with turbulent flow on Doppler ultrasound 3
  • AVOID therapeutic curettage in suspected pseudoaneurysm as it may worsen bleeding 3

Imaging

  • Transvaginal ultrasonography: First-line imaging to assess for retained products or structural abnormalities 1
  • Saline infusion sonohysterography: High sensitivity (96-100%) for assessing uterine and endometrial pathology 1
  • Pelvic MRI: Consider if cervical involvement is suspected 1

Monitoring

  • Monitor vital signs, bleeding amount, and hemoglobin levels
  • Repeat hemoglobin/hematocrit measurements to detect ongoing bleeding 1
  • Blood lactate should be used to estimate and monitor extent of bleeding and tissue hypoperfusion 1

Algorithm for Management

  1. Mild bleeding (no hemodynamic instability, minimal blood loss):

    • Continue oxytocin
    • Provide local compression
    • Monitor for 24-48 hours
  2. Moderate bleeding (increased but not life-threatening):

    • IV oxytocin infusion
    • Consider imaging to identify source
    • Prepare for possible surgical intervention
  3. Severe bleeding (hemodynamic instability or significant blood loss):

    • Immediate fluid resuscitation
    • High-dose oxytocin infusion
    • Urgent surgical intervention (repeat D&C or hysteroscopy)
    • Consider angiographic embolization if bleeding persists

Remember that bleeding patterns after D&C are variable, but heavy bleeding typically lasts only a few days 5. Persistent or recurrent bleeding warrants thorough investigation to rule out underlying pathology, especially in postmenopausal women 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hysteroscopy Coding Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Five-year follow-up of patients with recurrent postmenopausal bleeding.

Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.